Article Versions Notes

Stelter K, Alabssi A, Bonaterra GA, Schwarzbach H, Fendrich V, Slater EP, Kinscherf R, Hildebrandt W. Increased Myocardial MAO-A, Atrogin-1, and IL-1β Expression in Transgenic Mice with Pancreatic Carcinoma—Benefit of MAO-A Inhibition for Cardiac Cachexia. Biomedicines. 2024; 12(9):2009. https://doi.org/10.3390/biomedicines12092009

Stelter, Kira, Annalena Alabssi, Gabriel Alejandro Bonaterra, Hans Schwarzbach, Volker Fendrich, Emily P. Slater, Ralf Kinscherf, and Wulf Hildebrandt. 2024. "Increased Myocardial MAO-A, Atrogin-1, and IL-1β Expression in Transgenic Mice with Pancreatic Carcinoma—Benefit of MAO-A Inhibition for Cardiac Cachexia" Biomedicines 12, no. 9: 2009. https://doi.org/10.3390/biomedicines12092009

Stelter, K., Alabssi, A., Bonaterra, G. A., Schwarzbach, H., Fendrich, V., Slater, E. P., Kinscherf, R., & Hildebrandt, W. (2024). Increased Myocardial MAO-A, Atrogin-1, and IL-1β Expression in Transgenic Mice with Pancreatic Carcinoma—Benefit of MAO-A Inhibition for Cardiac Cachexia. Biomedicines, 12(9), 2009. https://doi.org/10.3390/biomedicines12092009